

Serge Bernasconi
Chief Executive Officer, MedTech EuropeMr Bernasconi has 40 years’ experience in the world of pharmaceuticals, medical technology and trade association leadership. He has worked in senior leadership position in companies such as Johnson & Johnson, Schering Plough (now Merck), and Medtronic. He has exercised his leadership in various geographical areas around the world, including, the US, Europe (France, Italy, Belgium, Switzerland), Turkey, the Middle East and Africa.
Throughout his career he has been involved in trade association activities and responsibilities both for the pharmaceutical industry and the MedTech Industry. Prior to become the CEO of Eucomed and EDMA and then MedTech Europe, he had been elected President of APIDIM (The French Association for the Promotion of Innovation in Medical Devices), and Vice President and Treasurer of SNITEM (French Medical Technology Industry Association).
Posted on 27.07.2021
This is no time to further unsettle EU medtech legislation


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 21.04.2016
Promoting diversity and innovation: European MedTech Week 2016


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 13.04.2016
Finding solutions to notified bodies challenge is crucial


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 04.03.2016
The role of medical technology in the 4th Industrial Revolution


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 26.11.2015
My 5 predictions for the medical technology industry in 2016


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 10.11.2015
During Trilogue, IVD and MD files should be treated on their own merits


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 22.10.2015
What’s with all the unnecessary complexity on the medical device revision?


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 19.05.2015
MedTech Week 2015 – Celebrating the value of medical technology


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 07.04.2015
The MedTech Industry and Startups: they NEED each other and should MEET each other


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 18.12.2014
My MedTech predictions for 2015 and their impact on our industry


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 20.11.2014
Let’s talk about the present and future of Continuing Medical Education


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 25.09.2014
DG SANCO or DG ENTR? Our value-based innovations will continue to benefit patients and healthcare systems in Europe


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 28.08.2014
The narrow view of medtech as a cost driver refuted… again


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 23.07.2014
Moving in the right direction – a fit-for-purpose HTA for devices and diagnostics


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 11.06.2014
The Value of MedTech at the World Cup and the Super Bowl


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 22.05.2014
Let’s close clinical loopholes for devices and not just ‘wallpaper over the cracks’


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 28.04.2014
Clinical Evidence “for In Vitro Diagnostics” should be exactly that: “for IVDs”


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 20.03.2014
MedTech will not be wiped out by Apples or Googles – but here’s something to think about


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 26.02.2014
Where are we again on the MDD and IVDD?


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 21.01.2014
A “healthy” agenda for the 2014 World Economic Forum in Davos


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 19.12.2013
2013: 5 MedTech Europe activities that will impact our industry for the years to come


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 22.11.2013
Regulations, assessments – in the end it’s about patients’ access to therapies


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 25.10.2013
Europe needs to invest in IVDs during times of austerity


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 16.10.2013
Always read the small print…on the ENVI proposal for the reprocessing of single-use medical devices


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 15.10.2013
Beyond rhetoric: MEPs need facts to make an informed decision on medical devices regulation


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 20.08.2013
My first twelve months at EDMA and Eucomed


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 23.07.2013
Have we got a speaker for you! Now you really cannot afford not to register for the MedTech Forum


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 20.06.2013
Medtech as a cost driver… or not?


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 23.05.2013
New rules, new markets – medical devices and diagnostics’ place in a changing Europe


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 24.04.2013
Getting regulation right for in vitro diagnostics and medical devices


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 20.03.2013
A tale of two workshops – A lively day at the European Parliament ENVI hearing


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 22.02.2013
All about meetings and events these days: ENVI hearing, Personalised Medicine and the 2013 MedTech Forum


By Serge Bernasconi, Chief Executive Officer, MedTech Europe
Posted on 28.01.2013
What to expect from EDMA, Eucomed and MedTech Europe in 2013


By Serge Bernasconi, Chief Executive Officer, MedTech Europe